Starpharma (ASX:SPL) has announced that its Australian developed VIRALEZE antiviral nasal spray achieved the maximum possible virucidal effect against the highly transmissible Omicron variant of SARS-CoV-2. …
Active agent in Australian-developed nasal spray highly active against 'Omicron'
March 2, 2022 Australian Biotech
Latest Video
New Stories
-
If this is an example of a bully playing hardball, it's not the companies
July 21, 2026 - - Latest News -
LTR Pharma secures national US manufacturing and fulfilment partner
July 21, 2026 - - Latest News -
Candidate shows antidepressant signal in difficult to treat depression
July 21, 2026 - - Latest News -
'Our access. Our medicines. Our vaccines. Our medical technology'
July 21, 2026 - - Latest News -
Novartis names Anne Harris to lead Australia and New Zealand
July 20, 2026 - - Latest News -
Why is the system slower than when there was no patient involvement or input?
July 20, 2026 - - Latest News -
No company in its right mind would risk a large private market for this outcome?
July 20, 2026 - - Latest News